Tomoya Mita

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

Masayuki Arakawa, Tomoya Mita, Kosuke Azuma et al. · Diabetes · 2010 · 536 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Gut Dysbiosis and Detection of “Live Gut Bacteria” in Blood of Japanese Patients With Type 2 Diabetes

Junko Sato, Akio Kanazawa, Fuki Ikeda et al. · Diabetes Care · 2014 · 450 citations

Life Sciences, Microbiology, Diabetology +14

The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance

Motoyuki Tamaki, Yoshio Fujitani, Akemi Hara et al. · Journal of Clinical Investigation · 2013 · 243 citations · Full text

Medicine, Endocrinology, Physiology +16

Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice

Nasib Ervinna, Tomoya Mita, Eisuke Yasunari et al. · Endocrinology · 2013 · 169 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Tomoya Mita, Naoto Katakami, Hidenori Yoshii et al. · Diabetes Care · 2015 · 163 citations

Medicine, Pharmacology, Pharmacotherapy +17